Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark R Denison

Showing results (91-100 of 103) with videos related to

Pageof 11
Sort By:
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
The New England Journal of Medicine|December 3, 2020
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationAlicia T Widge, Nadine G Rouphael, Lisa A Jackson, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2020
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2Kathleen Chiotos, Molly Hayes, David W Kimberlin, et al.
Journal of the Pediatric Infectious Diseases Society|September 12, 2020
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2Kathleen Chiotos, Molly Hayes, David W Kimberlin, et al.
Annals of the New York Academy of Sciences|January 25, 2023
Positive-strand RNA viruses-a Keystone Symposia reportJennifer Cable, Mark R Denison, Margaret Kielian, et al.
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
Pageof 11

Showing results (91-100 of 103) with videos related to

Sort By:
Pageof 11
Iscience|February 3, 2025
MERS-CoV spike vaccine-induced N-terminal domain-specific antibodies are more protective than receptor binding domain-specific antibodiesOlubukola M Abiona, Nianshuang Wang, Sarah R Leist, et al.
The New England Journal of Medicine|December 3, 2020
Durability of Responses after SARS-CoV-2 mRNA-1273 VaccinationAlicia T Widge, Nadine G Rouphael, Lisa A Jackson, et al.
The New England Journal of Medicine|July 15, 2020
An mRNA Vaccine against SARS-CoV-2 - Preliminary ReportLisa A Jackson, Evan J Anderson, Nadine G Rouphael, et al.
The New England Journal of Medicine|September 29, 2020
Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older AdultsEvan J Anderson, Nadine G Rouphael, Alicia T Widge, et al.
Journal of the Pediatric Infectious Diseases Society|April 23, 2020
Multicenter Initial Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2Kathleen Chiotos, Molly Hayes, David W Kimberlin, et al.
Journal of the Pediatric Infectious Diseases Society|September 12, 2020
Multicenter Interim Guidance on Use of Antivirals for Children With Coronavirus Disease 2019/Severe Acute Respiratory Syndrome Coronavirus 2Kathleen Chiotos, Molly Hayes, David W Kimberlin, et al.
Annals of the New York Academy of Sciences|January 25, 2023
Positive-strand RNA viruses-a Keystone Symposia reportJennifer Cable, Mark R Denison, Margaret Kielian, et al.
Research Square|March 10, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Trials|March 21, 2021
Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adultsWesley H Self, Thomas G Stewart, Allison P Wheeler, et al.
Chest|July 5, 2022
Neutralizing COVID-19 Convalescent Plasma in Adults Hospitalized With COVID-19: A Blinded, Randomized, Placebo-Controlled TrialWesley H Self, Allison P Wheeler, Thomas G Stewart, et al.
Pageof 11